UBS lowered the firm’s price target on Paychex (PAYX) to $145 from $155 and keeps a Neutral rating on the shares. A “lackluster” fiscal 2026 should keep Paychex range bound, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PAYX:
- Paychex price target lowered to $152 from $156 at Stifel
- Sell Rating for Paychex Amid Slower Growth and Integration Challenges
- Hold Rating on Paychex Amid Acquisition Delays and Investor Skepticism
- Paychex Reports Strong Revenue Growth and Strategic Acquisition
- Paychex price target lowered to $140 from $155 at Jefferies